386 related articles for article (PubMed ID: 21073405)
1. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
Sarris J; LaPorte E; Schweitzer I
Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
[TBL] [Abstract][Full Text] [Related]
2. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of kava in the treatment of anxiety disorders.
Singh YN; Singh NN
CNS Drugs; 2002; 16(11):731-43. PubMed ID: 12383029
[TBL] [Abstract][Full Text] [Related]
4. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.
Savage KM; Stough CK; Byrne GJ; Scholey A; Bousman C; Murphy J; Macdonald P; Suo C; Hughes M; Thomas S; Teschke R; Xing C; Sarris J
Trials; 2015 Nov; 16():493. PubMed ID: 26527536
[TBL] [Abstract][Full Text] [Related]
5. Piper methysticum (kava kava).
Altern Med Rev; 1998 Dec; 3(6):458-60. PubMed ID: 9855570
[TBL] [Abstract][Full Text] [Related]
6. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
[TBL] [Abstract][Full Text] [Related]
7. Kava (Piper methysticum).
J Soc Integr Oncol; 2009; 7(4):170-2. PubMed ID: 19883532
[No Abstract] [Full Text] [Related]
8. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G
Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072
[TBL] [Abstract][Full Text] [Related]
9. Kava.
Harv Womens Health Watch; 1998 Aug; 5(12):6. PubMed ID: 9713242
[No Abstract] [Full Text] [Related]
10. [Treatment with Kava--the root to ocombat stress].
Müller B; Komorek R
Wien Med Wochenschr; 1999; 149(8-10):197-201. PubMed ID: 10483680
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders.
Witte S; Loew D; Gaus W
Phytother Res; 2005 Mar; 19(3):183-8. PubMed ID: 15934028
[TBL] [Abstract][Full Text] [Related]
12. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop.
Thomsen M; Schmidt M
J Ethnopharmacol; 2021 Mar; 268():113582. PubMed ID: 33189846
[TBL] [Abstract][Full Text] [Related]
13. Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.
Sarris J; Byrne GJ; Bousman CA; Cribb L; Savage KM; Holmes O; Murphy J; Macdonald P; Short A; Nazareth S; Jennings E; Thomas SR; Ogden E; Chamoli S; Scholey A; Stough C
Aust N Z J Psychiatry; 2020 Mar; 54(3):288-297. PubMed ID: 31813230
[TBL] [Abstract][Full Text] [Related]
14. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.
Volz HP; Kieser M
Pharmacopsychiatry; 1997 Jan; 30(1):1-5. PubMed ID: 9065962
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).
Uebelhack R; Franke L; Schewe HJ
Pharmacopsychiatry; 1998 Sep; 31(5):187-92. PubMed ID: 9832350
[TBL] [Abstract][Full Text] [Related]
16. Kava: Piper methysticum.
Pepping J
Am J Health Syst Pharm; 1999 May; 56(10):957-8, 960. PubMed ID: 10365719
[No Abstract] [Full Text] [Related]
17. Safety of kava for patients with mild anxiety disorders.
Saeed SA; Bloch RM; Antonacci DJ
Am Fam Physician; 2008 Aug; 78(4):433-4. PubMed ID: 18756649
[No Abstract] [Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
Anke J; Ramzan I
J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
[TBL] [Abstract][Full Text] [Related]
19. Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure.
Feltenstein MW; Lambdin LC; Ganzera M; Ranjith H; Dharmaratne W; Nanayakkara NP; Khan IA; Sufka KJ
Phytother Res; 2003 Mar; 17(3):210-6. PubMed ID: 12672148
[TBL] [Abstract][Full Text] [Related]
20. [Kava-kava preparations--alternative anxiolytics].
Nowakowska E; Ostrowicz A; Chodera A
Pol Merkur Lekarski; 1998 Mar; 4(21):179-180a. PubMed ID: 9640076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
